Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

5 Top-Ranked ADRs That More Than Doubled The S&P 500 In 2019

Published 12/23/2019, 07:54 AM
Updated 07/09/2023, 06:31 AM

We are now in the last leg of 2019 and it’s been a superbly-rewarding year so far for Wall Street. The key U.S. indexes, the tech-heavy Nasdaq, the S&P 500, the small-cap index Russell 2000 and the blue-chip index Dow Jones rallied as much as 33.9%, 28.3%, 23.3% and 21.9% this year, respectively (as of Dec 20, 2019).

Key events this year that drove the global markets were the three Fed rate cuts, massive global-policy easing in the second half, announcements of the long-awaited phase-one U.S.-Sino and USMCA trade deal, and mild relaxations in the Brexit uncertainty, thanks to prime minister Boris Johnson’s easy win in the U.K. elections.

International Market Trailed the S&P 500 in 2019

However, international markets failed to keep up pace with the U.S. markets in 2019. Though there were pockets of weakness, the U.S. economy has actually been better positioned than most developed economies.

Ebb and flow in the trade war in the first nine months of the year, a slowdown in global economic activities and political crisis weighed on foreign stocks occasionally, causing those to trail the U.S. indexes. Equities in emerging nations, in fact, tanked to a 10-month low level in mid-2019.

The NYSE international 100 index returned 19% this year. International ETFs, like iShares Asia 50 ETF (NZ:AIA) was up 19.5%, iShares MSCI Emerging Markets ETF (NYSE:EEM) EEM rallied 13.6%, First Trust Latin America AlphaDEX Fund (ASX:FLN) gained 17.3%, developed market ETF iShares MSCI EAFE ETF EFA appreciated 17.9% and Vanguard FTSE Europe ETF VGK has been up 20.3% this year — all short of the U.S. market gains.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Global Policy Easing: A Great Savior in the Second Half

To abate growth concerns, a great cycle of global easing was set in motion. Australia, New Zealand, India, Turkey, Thailand, South Korea, Indonesia, Brazil, Mexico, South Africa and the ECB cut rates in the second half of this year. The ECB even re-launched the QE policy.

As many as 20 out of 32 central banks that Morgan Stanley (NYSE:MS) tracks are currently cutting interest rates with more easing on the horizon. Another key central bank, like Bank of Japan, has been maintaining an ultra-easy monetary policy, if not slashing further. A wave of cheap-money inflows in international markets have finally resulted in foreign equity rally in the second half.

Hidden Gems on the International Front

Despite threats, some international companies trading in the U.S. markets emerged as solid winners in 2019. In this context, we have shortlisted five ADR stocks that crushed the S&P 500 this year. These stocks carry a Zacks Rank #2 (Buy), at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Avita Medical Ltd. (NASDAQ:RCEL) — Up 694.6%

Headquartered in the U.K., Avita Medical Limited operates as a medical technology company. The company develops and distributes products in Regenerative and Respiratory Medicine. The stock has a market cap of $848.0 million.

Sibanye Gold Limited (NYSE:SBGL) — Up 222.9%

This South Africa-based gold mining company operates two gold mines: the Kloof Driefontein Complex (KDC) and the Beatrix gold mines. The stock has a market cap of $6.10 billion.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Vipshop Holdings Limited (NYSE:VIPS) — Up 164.8%

The company is an online discount retailer for brands. The company offers branded products to consumers in China through flash sales on its vipshop.com website. The stock has a market cap of $9.7 billion.

Avadel Pharmaceuticals PLC. (NASDAQ:AVDL) — Up 132.9%

This is a specialty pharmaceutical company, and its product pipeline consists of hospital and paediatrics. The company has a market cap of $225 million.

New Oriental Education & Technology Group Inc. (NYSE:EDU) — Up 125.8%

The company is the largest provider of private educational services in China based on the number of program offerings, total student enrollments and geographic presence. The stock has a market cap of $17.64 billion.

Zacks Top 10 Stocks for 2020

In addition to the stocks discussed above, would you like to know about our 10 top tickers for the entirety of 2020?

These 10 are painstakingly hand-picked from over 4,000 companies covered by the Zacks Rank. They are our primary picks to buy and hold. Start Your Access to the New Zacks Top 10 Stocks >>



Vipshop Holdings Limited (VIPS): Free Stock Analysis Report

iShares MSCI EAFE ETF (EFA): ETF Research Reports

Vanguard FTSE Europe ETF (VGK): ETF Research Reports

iShares Asia 50 ETF (AIA): ETF Research Reports

iShares MSCI Emerging Markets

Avadel Pharmaceuticals PLC. (AVDL): Free Stock Analysis Report

Sibanye Gold Limited (SBGL): Free Stock Analysis Report

New Oriental Education & Technology Group, Inc. (EDU): Free Stock Analysis Report
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Avita Medical Ltd. (RCEL): Free Stock Analysis Report

First Trust Latin America AlphaDEX Fund (FLN): ETF Research Reports

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.